The landscape of systemic therapy for early stage triple-negative breast cancer

Authors:

Abstract
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with higher risk of disease recurrence and mortality than other breast cancer subtypes. Historically, chemothera...
Funding Information
  • The Einstein Paul Calabresi Career Development Program (NIH 5K12CA132783-08)
  • NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA (UL1TR001073)

This publication has 68 references indexed in Scilit: